Intelerad Acquisition, Valuation, Funding & Investors

United Imaging Intelligence is a provider of AI-driven medical solutions covering diagnostics for all diseases. Based in Shanghai, China, it develops full-stack intelligent software for imaging analysis, radiotherapy planning, and healthcare workflows, integrating with United Imaging Healthcare's hardware.

Shanghai United Imaging Healthcare Co Ltd provides customers with high-performance medical imaging equipment, radiotherapy products, life science instruments, and medical digitalization and intelligent solutions. The company’s products include MRI systems, CT scanners, X-ray imaging equipment, molecular imaging systems, radiotherapy linear accelerators, and life science instruments.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Viz.ai is a San Francisco-based artificial intelligence company that develops a care-coordination platform for hospitals, using machine learning to analyze medical imaging such as CT scans and alert care teams to time-sensitive conditions. Originally focused on stroke detection, the platform has expanded to other conditions including pulmonary embolism and aortic disease, with FDA clearances and Medicare reimbursement supporting adoption. Viz.ai is deployed across more than 1,300 hospitals, connecting radiologists, emergency physicians, and specialists to speed diagnosis and treatment decisions.

RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia Pacific, Europe and the rest of the world.

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.

Hippocratic AI is a San Francisco-headquartered developer of large language models optimized for non-diagnostic healthcare interactions. Its platform deploys AI agents for tasks like preoperative education, discharge instructions, and chronic disease follow-ups via phone or text. Built on a multi-agent architecture with clinician oversight, the system includes an agent marketplace for specialties such as cardiology and oncology. Health systems integrate agents into workflows for patient outreach and triage support.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

IntelyCare is a Boston-headquartered platform founded in 2014 that matches licensed nurses and nursing assistants with per diem shifts at post-acute care facilities across the United States. The company leverages a mobile app and predictive analytics to fill shifts three times faster than industry averages, serving over 1,000 facilities in 25 states. IntelyCare's tools forecast staffing needs, optimize schedules, and provide real-time shift updates, helping providers manage labor shortages while offering nurses flexible work options with transparent pay rates.

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Uptake Technologies is a predictive analytics software company founded in 2014 by Groupon co-founders Brad Keywell and Eric Lefkofsky. It applies machine learning to sensor data from industrial equipment such as wind turbines, trucks, and fleets to predict failures and optimize maintenance across industries including energy, agriculture, mining, oil and gas, and trucking. Customers have included Berkshire Hathaway Energy, Caterpillar, and Panduit, with the platform used to flag issues such as gearbox faults before they cause costly breakdowns.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

EliseAI is a New York-based AI platform automating communications for multifamily housing and healthcare providers. It handles leasing inquiries, maintenance tickets, renewals, and appointments via SMS, email, voice, and chat in 17 languages. EliseAI integrates with Yardi, RealPage, and EHR systems like Epic, serving 2 million units and clinics in women's health and orthopedics with CRM modules.

Somatus is a McLean-headquartered value-based care provider for kidney disease patients. It integrates clinical services, technology, and nephrology partnerships with health plans to promote home dialysis and transplants. Founded in 2017, the company serves over 100,000 patients through 100 clinics nationwide.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

eMed is a New York-based telehealth provider offering on-demand clinical trials and chronic care management programs for GLP-1 medications targeting obesity and type 2 diabetes. The platform connects patients with board-certified clinicians via app-based consultations and at-home biometric kits shipped nationwide. eMed partners with Novo Nordisk for Wegovy distribution and ensures 95 percent adherence through remote monitoring.

Everlaw is an Oakland-headquartered legal technology platform for e-discovery and investigations. It provides cloud-based tools for document review, search, analytics, and production used by law firms, corporations, and government agencies. Features include predictive coding, timeline visualization, and collaboration workspaces to accelerate casework from data ingestion to trial. Founded in 2010, Everlaw serves Am Law 100 firms and Fortune 500 companies with data centers compliant to SOC 2 and FedRAMP standards across the United States.

NantHealth is a Culver City, California-headquartered precision medicine company that delivers genomic sequencing and molecular diagnostics through its Navify platform for oncology and rare diseases. The firm integrates multi-omic data to guide personalized treatment decisions in partnerships with hospitals across the United States.